Insulin Degludec Allows for Flexible Daily Dosing in Type 1 Diabetes, Providing Equal Glycemic Control with Less Nocturnal Hypoglycemia than Insulin Glargine Over 52 Weeks

Authors :: Jens Larsen
Stephen C. Bain
Chantal Mathieu
Priscilla Hollander
Edward Franek
B. Miranda-Palma
David Russell-Jones
Azhar Rana
John G. Cooper
Source :: Canadian Journal of Diabetes. 36:S56-S57
Publication Year :: 2012
Publisher :: Elsevier BV, 2012.

Subjects :: Insulin degludec
medicine.medical_specialty
Type 1 diabetes
Insulin glargine
business.industry
Endocrinology, Diabetes and Metabolism
General Medicine
medicine.disease
Nocturnal hypoglycemia
Endocrinology
Internal medicine
Internal Medicine
medicine
Dosing
business
Glycemic
medicine.drug

Tools